Uncategorized
Risk of dissociation with Retisert implant for uveitis increases over years
The 6-year cumulative risk of a spontaneous dissociation with the Retisert implant was 4.8%, according to new follow-up data from the Multicenter Uveitis Steroid Treatment trial.In all, 250 eyes of 146 patients were implanted with at least one Retisert (fluocinolone acetonide intraocular implant, Bausch + Lomb), of which there were 34 dissociations, either spontaneous or surgical, in 30 patients, meaning the drug pellet was no longer affixed to the strut, during the median follow-up time of 6 years.